RE:RE:RE:RE:Takeda, Hutchmed hook up on cancer drug for $1.13BGreat dialog regarding TLT's
potential on TLD 1433 for which I am extremely optimistic! However, can any of these possible deals be concluded during Q1 which would eliminate funding concern? Or maybe $400K/mo burn rate has dropped due to events that we're not aware of, deferred salaries or similar? ...which would have the effect of extending the timing. JMHO DYODD. Any expert thoughts on this?
Rumpl3StiltSkin wrote: Ok, I was thinking TLT might make a similar deal for 1433, then keep the other Osmium/Iridium based PDCs to go after Brain, Lung, Breast, etc. Would certainly bring in a ton of money.